Prospective MS Trial Proves Ocrelizumab Efficacy in Under-Represented PopulationsJune 13, 2024Multiple Sclerosis
In MS With Mild Symptoms, Non-Motor Symptoms Predict Later Mobility ProblemsJune 4, 2024Multiple Sclerosis
Vaccine Safety and DMT for Highly Active Multiple Sclerosis: New DataApril 26, 2024Multiple Sclerosis
MS and Epstein-Barr Virus: What Do We Know and Where Do We Go From Here?April 3, 2024Multiple Sclerosis
